Senior insider sale
Chief Accounting Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$1.31M
11.54K shares
What this filing means
LYON JOSEPH DOUGLAS plans to sell 11.54K shares of CORCEPT THERAPEUTICS INC valued at approximately $1.31M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/14/2026ACC: 0001973251-26-000037
Officer· Chief Accounting Officer
Since Jul 2020
11.54K
Shares to sell
$1.31M
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/14/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/14/2026 | Stock Option Exercise Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.54K
Market value
$175.7K
8/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$1.13M
9/14/2026
Total
Units
11.54K
Value
$1.31M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 1.54K | $175.7K | — | Completed |
| Planned — Approximate Date | ||||
9/14/2026 | 10K | $1.13M | NASDAQ | Planned |
| Total | 11.54K | $1.31M | ||